カテゴリー： Market Monitor Global, 世界, 医療/バイオ

注射ペプチド医薬品の世界市場見通し2023年-2029年

◆英語タイトル：Injection Peptide Drug Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8815 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月 ◆ページ数：66 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Injection Peptide Drug Market 調査レポートは次の情報を含め、グローバルにおけるの注射ペプチド医薬品市場規模と予測を収録しています。・世界の注射ペプチド医薬品市場：売上、2018年-2023年、2024年-2029年
・世界の注射ペプチド医薬品市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の注射ペプチド医薬品市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「静脈注射」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

注射ペプチド医薬品のグローバル主要企業は、Sanofi、 Teva、 Novo Nordisk、 Takeda、 Eli Lilly、 AstraZeneca、 Novartis、 AbbVie、 Ipsen、 Ferring、 Merck、 The Medicines、 J & Jなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、注射ペプチド医薬品のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の注射ペプチド医薬品市場：タイプ別、2018年-2023年、2024年-2029年
世界の注射ペプチド医薬品市場：タイプ別市場シェア、2022年
・静脈注射、皮下注射

世界の注射ペプチド医薬品市場：用途別、2018年-2023年、2024年-2029年
世界の注射ペプチド医薬品市場：用途別市場シェア、2022年
・癌、代謝障害、中枢神経系、その他

世界の注射ペプチド医薬品市場：地域・国別、2018年-2023年、2024年-2029年
世界の注射ペプチド医薬品市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における注射ペプチド医薬品のグローバル売上、2018年-2023年
・主要企業における注射ペプチド医薬品のグローバル売上シェア、2022年
・主要企業における注射ペプチド医薬品のグローバル販売量、2018年-2023年
・主要企業における注射ペプチド医薬品のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Sanofi、 Teva、 Novo Nordisk、 Takeda、 Eli Lilly、 AstraZeneca、 Novartis、 AbbVie、 Ipsen、 Ferring、 Merck、 The Medicines、 J & J

*************************************************************

・調査・分析レポートの概要
注射ペプチド医薬品市場の定義
市場セグメント
世界の注射ペプチド医薬品市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の注射ペプチド医薬品市場規模
世界の注射ペプチド医薬品市場規模：2022年 VS 2029年
世界の注射ペプチド医薬品市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの注射ペプチド医薬品の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の注射ペプチド医薬品製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：静脈注射、皮下注射
注射ペプチド医薬品のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：癌、代謝障害、中枢神経系、その他
注射ペプチド医薬品の用途別グローバル売上・予測

・地域別市場分析
地域別注射ペプチド医薬品市場規模 2022年と2029年
地域別注射ペプチド医薬品売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Sanofi、 Teva、 Novo Nordisk、 Takeda、 Eli Lilly、 AstraZeneca、 Novartis、 AbbVie、 Ipsen、 Ferring、 Merck、 The Medicines、 J & J
...

Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another. Peptides are distinguished from proteins on the basis of size, and as a benchmark can be understood to contain approximately 50 amino acids or less.
This report aims to provide a comprehensive presentation of the global market for Injection Peptide Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injection Peptide Drug. This report contains market size and forecasts of Injection Peptide Drug in global, including the following market information:
Global Injection Peptide Drug Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Injection Peptide Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Intravenous Injection Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Injection Peptide Drug include Sanofi, Teva, Novo Nordisk, Takeda, Eli Lilly, AstraZeneca, Novartis, AbbVie and Ipsen, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Injection Peptide Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Injection Peptide Drug Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Injection Peptide Drug Market Segment Percentages, by Type, 2022 (%)
Intravenous Injection
Subcutaneous Injection
Global Injection Peptide Drug Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Injection Peptide Drug Market Segment Percentages, by Application, 2022 (%)
Cancer
Metabolic Disorders
Central Nervous System
Other
Global Injection Peptide Drug Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Injection Peptide Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Injection Peptide Drug revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Injection Peptide Drug revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
Teva
Novo Nordisk
Takeda
Eli Lilly
AstraZeneca
Novartis
AbbVie
Ipsen
Ferring
Merck
The Medicines
J & J
Outline of Major Chapters:
Chapter 1: Introduces the definition of Injection Peptide Drug, market overview.
Chapter 2: Global Injection Peptide Drug market size in revenue.
Chapter 3: Detailed analysis of Injection Peptide Drug company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Injection Peptide Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Injection Peptide Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Injection Peptide Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Injection Peptide Drug Overall Market Size
2.1 Global Injection Peptide Drug Market Size: 2022 VS 2029
2.2 Global Injection Peptide Drug Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Injection Peptide Drug Players in Global Market
3.2 Top Global Injection Peptide Drug Companies Ranked by Revenue
3.3 Global Injection Peptide Drug Revenue by Companies
3.4 Top 3 and Top 5 Injection Peptide Drug Companies in Global Market, by Revenue in 2022
3.5 Global Companies Injection Peptide Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Injection Peptide Drug Players in Global Market
3.6.1 List of Global Tier 1 Injection Peptide Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Injection Peptide Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Injection Peptide Drug Market Size Markets, 2022 & 2029
4.1.2 Intravenous Injection
4.1.3 Subcutaneous Injection
4.2 By Type – Global Injection Peptide Drug Revenue & Forecasts
4.2.1 By Type – Global Injection Peptide Drug Revenue, 2018-2023
4.2.2 By Type – Global Injection Peptide Drug Revenue, 2024-2029
4.2.3 By Type – Global Injection Peptide Drug Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Injection Peptide Drug Market Size, 2022 & 2029
5.1.2 Cancer
5.1.3 Metabolic Disorders
5.1.4 Central Nervous System
5.1.5 Other
5.2 By Application – Global Injection Peptide Drug Revenue & Forecasts
5.2.1 By Application – Global Injection Peptide Drug Revenue, 2018-2023
5.2.2 By Application – Global Injection Peptide Drug Revenue, 2024-2029
5.2.3 By Application – Global Injection Peptide Drug Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Injection Peptide Drug Market Size, 2022 & 2029
6.2 By Region – Global Injection Peptide Drug Revenue & Forecasts
6.2.1 By Region – Global Injection Peptide Drug Revenue, 2018-2023
6.2.2 By Region – Global Injection Peptide Drug Revenue, 2024-2029
6.2.3 By Region – Global Injection Peptide Drug Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Injection Peptide Drug Revenue, 2018-2029
6.3.2 US Injection Peptide Drug Market Size, 2018-2029
6.3.3 Canada Injection Peptide Drug Market Size, 2018-2029
6.3.4 Mexico Injection Peptide Drug Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Injection Peptide Drug Revenue, 2018-2029
6.4.2 Germany Injection Peptide Drug Market Size, 2018-2029
6.4.3 France Injection Peptide Drug Market Size, 2018-2029
6.4.4 U.K. Injection Peptide Drug Market Size, 2018-2029
6.4.5 Italy Injection Peptide Drug Market Size, 2018-2029
6.4.6 Russia Injection Peptide Drug Market Size, 2018-2029
6.4.7 Nordic Countries Injection Peptide Drug Market Size, 2018-2029
6.4.8 Benelux Injection Peptide Drug Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Injection Peptide Drug Revenue, 2018-2029
6.5.2 China Injection Peptide Drug Market Size, 2018-2029
6.5.3 Japan Injection Peptide Drug Market Size, 2018-2029
6.5.4 South Korea Injection Peptide Drug Market Size, 2018-2029
6.5.5 Southeast Asia Injection Peptide Drug Market Size, 2018-2029
6.5.6 India Injection Peptide Drug Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Injection Peptide Drug Revenue, 2018-2029
6.6.2 Brazil Injection Peptide Drug Market Size, 2018-2029
6.6.3 Argentina Injection Peptide Drug Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Injection Peptide Drug Revenue, 2018-2029
6.7.2 Turkey Injection Peptide Drug Market Size, 2018-2029
6.7.3 Israel Injection Peptide Drug Market Size, 2018-2029
6.7.4 Saudi Arabia Injection Peptide Drug Market Size, 2018-2029
6.7.5 UAE Injection Peptide Drug Market Size, 2018-2029
7 Injection Peptide Drug Companies Profiles
7.1 Sanofi
7.1.1 Sanofi Company Summary
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Injection Peptide Drug Major Product Offerings
7.1.4 Sanofi Injection Peptide Drug Revenue in Global Market (2018-2023)
7.1.5 Sanofi Key News & Latest Developments
7.2 Teva
7.2.1 Teva Company Summary
7.2.2 Teva Business Overview
7.2.3 Teva Injection Peptide Drug Major Product Offerings
7.2.4 Teva Injection Peptide Drug Revenue in Global Market (2018-2023)
7.2.5 Teva Key News & Latest Developments
7.3 Novo Nordisk
7.3.1 Novo Nordisk Company Summary
7.3.2 Novo Nordisk Business Overview
7.3.3 Novo Nordisk Injection Peptide Drug Major Product Offerings
7.3.4 Novo Nordisk Injection Peptide Drug Revenue in Global Market (2018-2023)
7.3.5 Novo Nordisk Key News & Latest Developments
7.4 Takeda
7.4.1 Takeda Company Summary
7.4.2 Takeda Business Overview
7.4.3 Takeda Injection Peptide Drug Major Product Offerings
7.4.4 Takeda Injection Peptide Drug Revenue in Global Market (2018-2023)
7.4.5 Takeda Key News & Latest Developments
7.5 Eli Lilly
7.5.1 Eli Lilly Company Summary
7.5.2 Eli Lilly Business Overview
7.5.3 Eli Lilly Injection Peptide Drug Major Product Offerings
7.5.4 Eli Lilly Injection Peptide Drug Revenue in Global Market (2018-2023)
7.5.5 Eli Lilly Key News & Latest Developments
7.6 AstraZeneca
7.6.1 AstraZeneca Company Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Injection Peptide Drug Major Product Offerings
7.6.4 AstraZeneca Injection Peptide Drug Revenue in Global Market (2018-2023)
7.6.5 AstraZeneca Key News & Latest Developments
7.7 Novartis
7.7.1 Novartis Company Summary
7.7.2 Novartis Business Overview
7.7.3 Novartis Injection Peptide Drug Major Product Offerings
7.7.4 Novartis Injection Peptide Drug Revenue in Global Market (2018-2023)
7.7.5 Novartis Key News & Latest Developments
7.8 AbbVie
7.8.1 AbbVie Company Summary
7.8.2 AbbVie Business Overview
7.8.3 AbbVie Injection Peptide Drug Major Product Offerings
7.8.4 AbbVie Injection Peptide Drug Revenue in Global Market (2018-2023)
7.8.5 AbbVie Key News & Latest Developments
7.9 Ipsen
7.9.1 Ipsen Company Summary
7.9.2 Ipsen Business Overview
7.9.3 Ipsen Injection Peptide Drug Major Product Offerings
7.9.4 Ipsen Injection Peptide Drug Revenue in Global Market (2018-2023)
7.9.5 Ipsen Key News & Latest Developments
7.10 Ferring
7.10.1 Ferring Company Summary
7.10.2 Ferring Business Overview
7.10.3 Ferring Injection Peptide Drug Major Product Offerings
7.10.4 Ferring Injection Peptide Drug Revenue in Global Market (2018-2023)
7.10.5 Ferring Key News & Latest Developments
7.11 Merck
7.11.1 Merck Company Summary
7.11.2 Merck Business Overview
7.11.3 Merck Injection Peptide Drug Major Product Offerings
7.11.4 Merck Injection Peptide Drug Revenue in Global Market (2018-2023)
7.11.5 Merck Key News & Latest Developments
7.12 The Medicines
7.12.1 The Medicines Company Summary
7.12.2 The Medicines Business Overview
7.12.3 The Medicines Injection Peptide Drug Major Product Offerings
7.12.4 The Medicines Injection Peptide Drug Revenue in Global Market (2018-2023)
7.12.5 The Medicines Key News & Latest Developments
7.13 J & J
7.13.1 J & J Company Summary
7.13.2 J & J Business Overview
7.13.3 J & J Injection Peptide Drug Major Product Offerings
7.13.4 J & J Injection Peptide Drug Revenue in Global Market (2018-2023)
7.13.5 J & J Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Injection Peptide Drug Market Opportunities & Trends in Global Market
Table 2. Injection Peptide Drug Market Drivers in Global Market
Table 3. Injection Peptide Drug Market Restraints in Global Market
Table 4. Key Players of Injection Peptide Drug in Global Market
Table 5. Top Injection Peptide Drug Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Injection Peptide Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Injection Peptide Drug Revenue Share by Companies, 2018-2023
Table 8. Global Companies Injection Peptide Drug Product Type
Table 9. List of Global Tier 1 Injection Peptide Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Injection Peptide Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Injection Peptide Drug Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Injection Peptide Drug Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Injection Peptide Drug Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Injection Peptide Drug Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Injection Peptide Drug Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Injection Peptide Drug Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Injection Peptide Drug Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Injection Peptide Drug Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Injection Peptide Drug Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Injection Peptide Drug Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Injection Peptide Drug Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Injection Peptide Drug Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Injection Peptide Drug Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Injection Peptide Drug Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Injection Peptide Drug Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Injection Peptide Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Injection Peptide Drug Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Injection Peptide Drug Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Injection Peptide Drug Revenue, (US$, Mn), 2024-2029
Table 30. Sanofi Company Summary
Table 31. Sanofi Injection Peptide Drug Product Offerings
Table 32. Sanofi Injection Peptide Drug Revenue (US$, Mn) & (2018-2023)
Table 33. Sanofi Key News & Latest Developments
Table 34. Teva Company Summary
Table 35. Teva Injection Peptide Drug Product Offerings
Table 36. Teva Injection Peptide Drug Revenue (US$, Mn) & (2018-2023)
Table 37. Teva Key News & Latest Developments
Table 38. Novo Nordisk Company Summary
Table 39. Novo Nordisk Injection Peptide Drug Product Offerings
Table 40. Novo Nordisk Injection Peptide Drug Revenue (US$, Mn) & (2018-2023)
Table 41. Novo Nordisk Key News & Latest Developments
Table 42. Takeda Company Summary
Table 43. Takeda Injection Peptide Drug Product Offerings
Table 44. Takeda Injection Peptide Drug Revenue (US$, Mn) & (2018-2023)
Table 45. Takeda Key News & Latest Developments
Table 46. Eli Lilly Company Summary
Table 47. Eli Lilly Injection Peptide Drug Product Offerings
Table 48. Eli Lilly Injection Peptide Drug Revenue (US$, Mn) & (2018-2023)
Table 49. Eli Lilly Key News & Latest Developments
Table 50. AstraZeneca Company Summary
Table 51. AstraZeneca Injection Peptide Drug Product Offerings
Table 52. AstraZeneca Injection Peptide Drug Revenue (US$, Mn) & (2018-2023)
Table 53. AstraZeneca Key News & Latest Developments
Table 54. Novartis Company Summary
Table 55. Novartis Injection Peptide Drug Product Offerings
Table 56. Novartis Injection Peptide Drug Revenue (US$, Mn) & (2018-2023)
Table 57. Novartis Key News & Latest Developments
Table 58. AbbVie Company Summary
Table 59. AbbVie Injection Peptide Drug Product Offerings
Table 60. AbbVie Injection Peptide Drug Revenue (US$, Mn) & (2018-2023)
Table 61. AbbVie Key News & Latest Developments
Table 62. Ipsen Company Summary
Table 63. Ipsen Injection Peptide Drug Product Offerings
Table 64. Ipsen Injection Peptide Drug Revenue (US$, Mn) & (2018-2023)
Table 65. Ipsen Key News & Latest Developments
Table 66. Ferring Company Summary
Table 67. Ferring Injection Peptide Drug Product Offerings
Table 68. Ferring Injection Peptide Drug Revenue (US$, Mn) & (2018-2023)
Table 69. Ferring Key News & Latest Developments
Table 70. Merck Company Summary
Table 71. Merck Injection Peptide Drug Product Offerings
Table 72. Merck Injection Peptide Drug Revenue (US$, Mn) & (2018-2023)
Table 73. Merck Key News & Latest Developments
Table 74. The Medicines Company Summary
Table 75. The Medicines Injection Peptide Drug Product Offerings
Table 76. The Medicines Injection Peptide Drug Revenue (US$, Mn) & (2018-2023)
Table 77. The Medicines Key News & Latest Developments
Table 78. J & J Company Summary
Table 79. J & J Injection Peptide Drug Product Offerings
Table 80. J & J Injection Peptide Drug Revenue (US$, Mn) & (2018-2023)
Table 81. J & J Key News & Latest Developments
List of Figures
Figure 1. Injection Peptide Drug Segment by Type in 2022
Figure 2. Injection Peptide Drug Segment by Application in 2022
Figure 3. Global Injection Peptide Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Injection Peptide Drug Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Injection Peptide Drug Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Injection Peptide Drug Revenue in 2022
Figure 8. By Type - Global Injection Peptide Drug Revenue Market Share, 2018-2029
Figure 9. By Application - Global Injection Peptide Drug Revenue Market Share, 2018-2029
Figure 10. By Type - Global Injection Peptide Drug Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Injection Peptide Drug Revenue Market Share, 2018-2029
Figure 12. By Application - Global Injection Peptide Drug Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Injection Peptide Drug Revenue Market Share, 2018-2029
Figure 14. By Region - Global Injection Peptide Drug Revenue Market Share, 2018-2029
Figure 15. By Country - North America Injection Peptide Drug Revenue Market Share, 2018-2029
Figure 16. US Injection Peptide Drug Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Injection Peptide Drug Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Injection Peptide Drug Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Injection Peptide Drug Revenue Market Share, 2018-2029
Figure 20. Germany Injection Peptide Drug Revenue, (US$, Mn), 2018-2029
Figure 21. France Injection Peptide Drug Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Injection Peptide Drug Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Injection Peptide Drug Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Injection Peptide Drug Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Injection Peptide Drug Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Injection Peptide Drug Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Injection Peptide Drug Revenue Market Share, 2018-2029
Figure 28. China Injection Peptide Drug Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Injection Peptide Drug Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Injection Peptide Drug Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Injection Peptide Drug Revenue, (US$, Mn), 2018-2029
Figure 32. India Injection Peptide Drug Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Injection Peptide Drug Revenue Market Share, 2018-2029
Figure 34. Brazil Injection Peptide Drug Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Injection Peptide Drug Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Injection Peptide Drug Revenue Market Share, 2018-2029
Figure 37. Turkey Injection Peptide Drug Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Injection Peptide Drug Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Injection Peptide Drug Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Injection Peptide Drug Revenue, (US$, Mn), 2018-2029
Figure 41. Sanofi Injection Peptide Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Teva Injection Peptide Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Novo Nordisk Injection Peptide Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Takeda Injection Peptide Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Eli Lilly Injection Peptide Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. AstraZeneca Injection Peptide Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Novartis Injection Peptide Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. AbbVie Injection Peptide Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Ipsen Injection Peptide Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Ferring Injection Peptide Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Merck Injection Peptide Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. The Medicines Injection Peptide Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. J & J Injection Peptide Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 注射ペプチド医薬品の世界市場見通し2023年-2029年(Injection Peptide Drug Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

注射ペプチド医薬品の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp